Company Filing History:
1 out of 1 
1 out of 3 Years Active: 2022-2025
Title: The Innovative Contributions of Casimiro Luca Gigliotti
Introduction
Casimiro Luca Gigliotti is a notable inventor based in Novara, Italy. He has made significant contributions to the field of medical therapeutics, particularly in the development of anti-tumor agents and treatments for bone diseases. With a total of 2 patents, his work has the potential to impact the lives of many patients suffering from serious health conditions.
Latest Patents
Gigliotti's latest patents include groundbreaking innovations. The first patent focuses on "Anti-tumor therapeutic agents based on B7h receptor ligands." This invention comprises novel anti-tumor agents that utilize ligands of the B7h receptor, which are loaded in biocompatible micro- or nano-carriers. These agents are designed to bind to the B7h receptor and activate its activity, offering new avenues for cancer treatment. The second patent, titled "Ligands of B7H receptor in the treatment of osteopenia and osteoporosis," reveals a novel application of B7h receptor ligands for treating osteoporosis and osteopenia. This patent also highlights the B7h receptor as a target for screening pharmaceutical agents that could be beneficial in treating these bone diseases.
Career Highlights
Throughout his career, Gigliotti has worked with various organizations that focus on innovative medical research. Notably, he has been associated with Novaicos Immunotherapeutics S.r.l. and the Università Degli Studi Del Piemonte Orientale "Amedeo Avogadro." His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Gigliotti has collaborated with esteemed colleagues such as Umberto Dianzani and Elena Boggio. These partnerships have enriched his research and fostered an environment of innovation and discovery.
Conclusion
Casimiro Luca Gigliotti's contributions to medical therapeutics through his patents and collaborations highlight his role as a significant inventor in the field. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer and bone health.